Trial Profile
Evaluating the effect of N-acetyl cysteine on the Early Remodeling Biomarkers (MMPs & NT-Pro-BNP) in patients following acute myocardial infarction.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary)
- Indications Myocardial infarction
- Focus Biomarker; Therapeutic Use
- 18 Oct 2011 New trial record